Tag Archives: Cancer

FDA Approves Ibrance (palbociclib) for the Treatment of Men with HR+, HER2- Metastatic Breast Cancer

Print this page April 4, 2019 — Pfizer (NYSE:PFE) today announced that the U.S. Food and Drug Administration (FDA) approved a supplemental New Drug Application (sNDA) to expand the indications for Ibrance (palbociclib) in combination with an aromatase inhibitor or fulvestrant to include men with hormone receptor-positive (HR+), human epidermal growth factor receptor 2-negative (HER2-)… Read More »

Second Jury Trial Implicates Roundup in Lymphatic Cancer

August 10, 2018, a jury ruled in favor of plaintiff Dewayne Johnson in a truly historic case against Monsanto1 (now owned by Bayer AG2,3). Johnson — the first of several thousand pending legal cases — claimed Monsanto’s herbicide Roundup caused his Non-Hodgkin lymphoma. Forty-six-year-old Johnson sprayed about 150 gallons of Roundup 20 to 40 times… Read More »